Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Liabilities from Discontinued Operations (2021 - 2025)

Updated

Ligand Pharmaceuticals' Liabilities from Discontinued Operations was $35.69 million in Q2 2025, up 39.9% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Liabilities from Discontinued Operations (2021 - 2025) Analysis & Trends

At the end of FY2021, Liabilities from Discontinued Operations at Ligand Pharmaceuticals came in at $55.53 million.

  • The Q2 2025 figure marks the highest quarterly Liabilities from Discontinued Operations since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 35.69 Mn
Mar 31, 2025 25.51 Mn
Dec 31, 2021 55.53 Mn
API Access

Ligand Pharmaceuticals Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=LGND&period=max&api_key=YOUR_API_KEY